Materialsammlung zur internen Radiodekontamination von Personen

122
123. Rencová J., Volf V., Jones M. M., Singh P. K., “Mobilization and detoxi. cation
of polonium-210 in rats by 2,3-dimercaptosuccinic acid and its derivatives”,
Int. J. Radiat. Biol 76(10), pp. 1409 – 1415 (2000)
124. Rencová J., Volf V., Jones M. M., Singh P. K., Filgas R., “Bis-dithiocarbamates:
Effective Chelating Agents for Mobilization of Polonium-210 from
Rat”, Int. J. Radiat. Biol., 67(2), pp. 229 –234 (1995)
125. Report of the Medical Preparedness and Response Subgroup of the Working
Group on Radiological Dispersal Device (RDD) Preparedness, Department
of Homeland Security, December 2003
126. Roessler G., „Why 210 Po?“, Health Physics News 35(2), pp. 2 – 9 (2007)
127. Sawicki M. et al., “Bisphosphonate Sequestering Agents. Synthesis and Preliminary
Evaluation for in vitro and in vivo Uranium(VI) Chelation”, Eur. J.
Med. Chem. (2008), doi: 10.1016/j.ejmech.2008.01.018
128. Seed T. M., “Radiation Protectants: Current Status and Future Prospects“,
Health Phys. 89(5), pp. 531–545 (2005)
129. Semmler M., Seitz J., Erbe F., Mayer P., Heyder J., Oberdörster G., Kreyling
W. G., „Long-Term Clearance Kinetics of Inhaled Ultrafine Insoluble Iridium
Particles from the Rat Lung, Including Transient Translocation into Secondary
Organs“, Inhalation Toxicology 16, pp. 453–459 (2004)
130. Serandour, A. L. et al., “Decorporation of Plutonium by Pulmonary Administration
of Ca-DTPA Dry Powder: A Study in Rat after Lung Contamination
with Different Plutonium Forms”, Radiation Protection Dosimetry 2007
Jun 11, epub ahead of print
131. Smith J. M., Ansari A., Harper F.T., „Hospital Management of Mass Radiological
Casualties: Reassessing Exposures from Contaminated Victims of an
Exploded Radiological Dispersal Device“, Health Phys. 89(5), pp.513–520
(2005)
132. Sonzogni A. A., Tuli J. K., Winchell D. F., NuDat database version 2.4,
Brookhaven National Laboratory, http://www.nndc.bnl.gov/nudat2/, zugegriffen
am 9. Januar 2008
133. Steffen K. J., Mitchell J. E., Roerig J. L., Lancaster K. L., „The Eating Disorders
Medicine Cabinet Revisited: A Clinician’s Guide to Ipecac and Laxatives“,
Int. J. Eat. Disord. 40, pp. 360–368 (2007)
134. Strahlenschutzkommission, „Radiologische Bewertung des Plutoniums“,
Veröffentlichungen der Strahlenschutzkommission, Band 15 (1989)
135. Strahlenschutzkommission: „Fachgespräch zur Iodblockade der Schilddrüse
bei kerntechnischen Unfällen“ (2001)
136. Strahlenschutzkommission: „Verwendung von Iodtabletten zur Iodblockade
der Schilddrüsen bei einem kerntechnischen Unfall“ (Iodmerkblätter) (2004)
137. Swindon T. N., „Manual on the Medical Management of Individuals Involved
in Radiation Accidents“, Australian Radiation Protection and Nuclear
Safety Agency (ARPANSA), Technical Report 131, ISSN 1443-0843 (2000)
138. Taylor D. M., Stradling G. N., Ménétrier F., “Biokinetics of Radionuclides
and Treatment of Accidental Intakes“, Rad. Prot. Dosim. 105 (1–4), pp. 637–
640 (2003)
139. Taylor D.M., Hodgson S.A. and Stradling N., „Treatment of Human Contamination
with Plutonium and Americium: Would orally administered Ca- Or
Zn-DTPA be effective?“, Rad. Prot. Dosim. 2007 Jun 7, epub ahead of print